Antibiotics

It is produced by the strain of Cochlioblus lunata. It has anti-mould (partial) and bacterial (individual) effects.

It is produced by the strain of Cochlioblus lunata. It has anti-mould (partial) and bacterial (individual) effects.

It is produced by the strain of Fusarium oxysporum var. lycopersici, Fus. oxysporum var. vasinfectum, Fus. oxysporum var. melonis. It has the inhibitory effect of lactobacillus casei, and it is a plant toxin.

It is produced by the strain of Str. lydicus NRRL 2433. It has a broad spectrum of anti-bacterial and mycobacterial effects. Biotin can counteract its antibacterial activity in the synthetic medium.

It is produced by the strain of Micromonospora chalcea. It's an antibiotic.

It is produced by the strain of Micromonospora chalcea. It's an antibiotic.

It is produced by the strain of Micromonospora chalcea. It's an antibiotic.

It is produced by the strain of Stenotrophomonas maltophilia. It is a broad-spectrum antifungal antibiotic that has no antibacterial effect against gram-positive and gram-negative bacteria.

It is produced by the strain of Str. prasinopilosus KC-7367. It has anti-fungal effect. Maniwamycin A has stronger anti-fungal effect than Maniwamycin B, but it has no anti-bacterial effect.

It is produced by the strain of Str. prasinopilosus KC-7367. It has anti-fungal effect. Maniwamycin B has weaker anti-fungal effect than Maniwamycin A, but it has no anti-bacterial effect.

It is produced by the strain of Str. virginiae var. 4243-MTt1. It's an aminoglycoside antibiotic. It has anti-bacterium, mycobacterium and beer yeast effects. Trehalose does not counteract its antibacterial effect against Mycobacterium 607.

It is produced by the strain of Str. sp. WB-83. It has anti-gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-gram-negative bacteria, and has no effect on fungi. It inhibits RAS Faraday base transfer with IC50 of 5 μmol/L. It has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).

It is produced by the strain of Str. sp. WB-83. It has anti-gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-gram-negative bacteria, and has no effect on fungi. It inhibits RAS Faraday base transfer with IC50 of 5 μmol/L. It has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).

It is produced by the strain of Str. sp. WB-83. It has anti-gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-gram-negative bacteria, and has no effect on fungi. It inhibits RAS Faraday base transfer with IC50 of 5 μmol/L. It has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).

It is produced by the strain of Marasmius conigenus 6890. It's a terpene antibiotic. It has anti-gram-positive bacteria effect. It also has anti-gram-negative bacteria, mycobacteria and fungi effect, but the effect is weak.

Marcellomycin is produced by the strain of Actinosporangium bohemicum sp. nov. C-36145. It is a glycoside and quinone antibiotic. It has anti-gram-positive bacteria effect, especially has strong effect on streptococcus. It also has effect on individual gram-negative bacteria, but the activity is not strong. Marcellomycin was 4 times stronger than Musettamycin in the treatment of leukemia L-1210.

Musettamycin is produced by the strain of Actinosporangium bohemicum sp. nov. C-36145. It is a glycoside and quinone antibiotic. It has anti-gram-positive bacteria effect, especially has strong effect on streptococcus. It also has effect on individual gram-negative bacteria, but the activity is not strong. Marcellomycin was 4 times stronger than Musettamycin in the treatment of leukemia L-1210.

It is produced by the strain of Str. hygroscopicus B-5050. It's a macrolide antibiotic. It has the activity against gram-positive bacteria and mycoplasma. It has anti-mycobacterial effect but the effect is not strong. Serum dose not affect its antibacterial activity. It has the effect of protecting gram-positive bacterial infection mice, and the therapeutic dose is similar to styloleomycin.

It is produced by the strain of Str. hygroscopicus B-5050. It's a macrolide antibiotic. It has the activity against gram-positive bacteria and mycoplasma. Serum dose not affect its antibacterial activity. It has the effect of protecting gram-positive bacterial infection mice, and the therapeutic dose is similar to styloleomycin.

It is produced by the strain of Str. hygroscopicus B-5050. It's a macrolide antibiotic. It has the activity against gram-positive bacteria and mycoplasma. Serum dose not affect its antibacterial activity. It has the effect of protecting gram-positive bacterial infection mice, and the therapeutic dose is similar to styloleomycin.